These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16594591)
1. Urine N-telopeptide excretion in dogs with appendicular osteosarcoma. Lacoste H; Fan TM; de Lorimier LP; Charney SC J Vet Intern Med; 2006; 20(2):335-41. PubMed ID: 16594591 [TBL] [Abstract][Full Text] [Related]
2. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. Fan TM; de Lorimier LP; O'Dell-Anderson K; Lacoste HI; Charney SC J Vet Intern Med; 2007; 21(3):431-9. PubMed ID: 17552447 [TBL] [Abstract][Full Text] [Related]
3. A comparison of five different bone resorption markers in osteosarcoma-bearing dogs, normal dogs, and dogs with orthopedic diseases. Lucas PW; Fan TM; Garrett LD; Griffon DJ; Wypij JM J Vet Intern Med; 2008; 22(4):1008-13. PubMed ID: 18564220 [TBL] [Abstract][Full Text] [Related]
4. Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. Fan TM; Charney SC; de Lorimier LP; Garrett LD; Griffon DJ; Gordon-Evans WJ; Wypij JM J Vet Intern Med; 2009; 23(1):152-60. PubMed ID: 19175734 [TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age. Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy. Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101 [TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). Ehrhart N; Dernell WS; Hoffmann WE; Weigel RM; Powers BE; Withrow SJ J Am Vet Med Assoc; 1998 Oct; 213(7):1002-6. PubMed ID: 9776998 [TBL] [Abstract][Full Text] [Related]
9. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma. Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720 [TBL] [Abstract][Full Text] [Related]
10. Bone turnover in neonates: changes of urinary excretion rate of collagen type I cross-linked peptides during the first days of life and influence of gestational age. Mora S; Prinster C; Bellini A; Weber G; Proverbio MC; Puzzovio M; Bianchi C; Chiumello G Bone; 1997 Jun; 20(6):563-6. PubMed ID: 9177872 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. Fan TM; de Lorimier LP; Charney SC; Hintermeister JG J Vet Intern Med; 2005; 19(1):74-80. PubMed ID: 15715051 [TBL] [Abstract][Full Text] [Related]
12. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism. Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811 [TBL] [Abstract][Full Text] [Related]
13. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. Fan TM; de Lorimier LP; Garrett LD; Lacoste HI J Vet Intern Med; 2008; 22(2):380-7. PubMed ID: 18346146 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of P16 expression in canine appendicular osteosarcoma. Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676 [TBL] [Abstract][Full Text] [Related]
15. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma. Story AL; Boston SE; Kilkenny JJ; Singh A; Woods JP; Culp WTN; Skorupski KA; Lu X J Vet Intern Med; 2017 Jul; 31(4):1159-1162. PubMed ID: 28503759 [TBL] [Abstract][Full Text] [Related]
17. Correlation of urine type I collagen-cross-linked N telopeptide levels with bone scintigraphic results in prostate cancer patients. Fukumitsu N; Uchiyama M; Mori Y; Yanada S; Hatano T; Igarashi H; Kishimoto K; Nakada J; Yoshihiro A; Harada J Metabolism; 2002 Jul; 51(7):814-8. PubMed ID: 12077723 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of prostate specific antigen (PSA), C-terminal propeptide of blood type I procollagen (PICP) and urine type I collagen-crosslinked N telopeptide (NTx) levels using bone scintigraphy in prostate cancer patients. Fukumitsu N; Uchiyama M; Mori Y; Kishimoto K; Nakada J Ann Nucl Med; 2003 Jun; 17(4):297-303. PubMed ID: 12932112 [TBL] [Abstract][Full Text] [Related]
19. Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice. Wolfe TD; Pillai SP; Hildreth BE; Lanigan LG; Martin CK; Werbeck JL; Rosol TJ Clin Exp Metastasis; 2011 Apr; 28(4):377-89. PubMed ID: 21374084 [TBL] [Abstract][Full Text] [Related]
20. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Rosen HN; Dresner-Pollak R; Moses AC; Rosenblatt M; Zeind AJ; Clemens JD; Greenspan SL Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]